Cite Filings / ORKA / 0001950047-26-009701
Feed Companies Filings Check
Sign in
144

Sale of Securities

Oruka Therapeutics, Inc. · Filed 2026-09-21 · Acc 0001950047-26-009701

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-10-01 144 Sale of Securities
  • 2026-09-21 144 Sale of Securities
  • 2026-09-21 4 Senior Vice President, Finance sold 533 shares at $95.75 ($51,035)
  • 2026-09-21 4 General Counsel sold 10,000 shares at an average $93.64 ($936,417)
  • 2026-09-15 4 Chief Medical Officer sold 7,947 shares at an average $92.38 ($734,145)
  • 2026-09-15 4 Senior Vice President, Finance sold 10,019 shares at an average $92.43 ($926,010)
  • 2026-09-01 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…